Galanin attenuates retention of one-trial reward learning.
暂无分享,去创建一个
J. Lake | D. Malin | B. May | M. Crothers | R. E. Plotner | S. J. Radulescu | B. Novy | A. E. Lett-Brown | L. D. Osgood
[1] J. Lake,et al. Analog of neuropeptide FF attenuates morphine abstinence syndrome , 1991, Peptides.
[2] Christopher L. Hunter,et al. Methanesulfonyl fluoride enhances one-trial reward learning in mid-aged rats , 1991, Neurobiology of Aging.
[3] J. Lake,et al. FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat , 1990, Peptides.
[4] Y. Ben-Ari,et al. Galanin and Glibenclamide Modulate the Anoxic Release of Glutamate in Rat CA3 Hippocampal Neurons , 1990, The European journal of neuroscience.
[5] J. Crawley,et al. Co-existence of galanin and acetylcholine: is galanin involved in memory processes and dementia? , 1989, Trends in Neurosciences.
[6] D. Menétrey,et al. Cholinergic and peptidergic projections from the medial septum and the nucleus of the diagonal band of broca to dorsal hippocampus, cingulate cortex and olfactory bulb: A combined wheatgerm agglutinin-apohorseradish peroxidase-gold immunohistochemical study , 1989, Neuroscience.
[7] R. Nicoll,et al. Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus. , 1989, European journal of pharmacology.
[8] M. Beal,et al. Galanin‐Like Immunoreactivity Is Unchanged in Alzheimer's Disease and Parkinson's Disease Dementia Cerebral Cortex , 1988, Journal of neurochemistry.
[9] V. Chan‐Palay. Galanin hyperinnervates surviving neurons of the human basal nucleus of meynert in dementias of alzheimer's and parkinson's disease: A hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia , 1988, The Journal of comparative neurology.
[10] T. Hökfelt,et al. Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim maze , 1988, Neuroscience Letters.
[11] T. Hökfelt,et al. Galanin inhibits the muscarinic stimulation of phosphoinositide turnover in rat ventral hippocampus. , 1988, European journal of pharmacology.
[12] E. Sundström,et al. Effects of galanin on 5-HT neurons in the rat CNS. , 1988, European journal of pharmacology.
[13] M. Er̀rington,et al. Increase in [3H]glutamate release from slices of dentate gyrus and hippocampus following classical conditioning in the rat , 1987, Behavioural Brain Research.
[14] T. Hökfelt,et al. Evidence for an inhibitory effect of the peptide galanin on dopamine release from the rat median eminence , 1987, Neuroscience Letters.
[15] W. Yau,et al. Evidence for galanin as an inhibitory neuropeptide on myenteric cholinergic neurons in the guinea pig small intestine , 1986, Neuroscience Letters.
[16] T. Hökfelt,et al. Galanin-like immunoreactivity in cholinergic neurons of the septum-basal forebrain complex projecting to the hippocampus of the rat , 1985, Brain Research.
[17] Michael J. Berridge,et al. Inositol trisphosphate, a novel second messenger in cellular signal transduction , 1984, Nature.
[18] P. Davies,et al. SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.
[19] G. Lynch,et al. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 , 1986, Nature.